Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease PROTOPIC Ointment Can Help Prevent Eczema Flares
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò€  Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
generic viagra online
Appetite-Stimulating Hormone Is First Potential Medical Treatment For Frailty In Older Women
Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a study presented today by Penn Medicine researchers at ENDO, The Endocrine Society"s 91st Annual Meeting. Ghrelin, a hormone that stimulates appetite, was administered to older women diagnosed with frailty, a common geriatric syndrome characterized by unintentional weight loss, weakness, exhaustion and low levels of anabolic hormones which increases risk of falls, hospitalizations, disability, and death. Those who received ghrelin infusions consumed 51 percent more calories than the placebo group, with an increase in carbohydrate and protein intake, not fat. Their growth hormone levels were also higher throughout the ghrelin infusion.
News of the day
In Patients With Diabetes And Stable Heart Disease, Medical Therapy Equal To Bypass, Angioplasty
Optimal medical therapy for patients with diabetes and stable coronary heart disease is equally effective at lowering the risk of death, heart attack, and stroke as prompt revascularization procedures with either coronary bypass surgery or angioplasty, according to results from an international multicenter clinical trial supported by the National Institutes of Health. Optimal medical therapy includes intensive drug therapy and lifestyle interventions, such as dietary changes and smoking cessation.
Health Insurance

MS Society Appoints New Director

The MS Society has appointed Sue Farrington to its newly created role of Director of Information and Education. Sue was formerly Director of Corporate Affairs at CSV. In her new role, which starts this month, Sue is responsible for the management of the MS Society"s information for people affected by MS - through its website, annual conference programme and publications team. Sue will also be overseeing a drive to improve the Society"s professional education programme. Speaking about her new role, Sue said: "As technologies converge, the MS Society has a great opportunity to respond to people"s information needs in the way that they want." Sue joins the charity with 14 years of senior management experience behind her. In her last role at CSV - the UK"s largest volunteering and training organisation - she was responsible for communications, broadcast and campaigns. Previous to that she was Director of Media at the company, providing communications support and media employment training. Between 2004 and 2008 Sue served on the Ofcom Advisory Committee for England. MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009